Agriculture, Rural Development, and Related Agencies Appropriations for 1985: Agricultural programsU.S. Government Printing Office, 1984 |
From inside the book
Results 1-5 of 56
Page 276
... labeling changes to make information about sodium more readily available , to work to educate consumers about sodium , to encourage the industry voluntarily to reduce the amount of sodium in processed foods , and to monitor 276.
... labeling changes to make information about sodium more readily available , to work to educate consumers about sodium , to encourage the industry voluntarily to reduce the amount of sodium in processed foods , and to monitor 276.
Page 277
... labeling , and that is a fourfold increase from the 7.5 percent of processed foods with such labeling in 1978 . The same survey also shows that out of the 51 groups for which we have detailed sales volume , 42 have some sodium labeling ...
... labeling , and that is a fourfold increase from the 7.5 percent of processed foods with such labeling in 1978 . The same survey also shows that out of the 51 groups for which we have detailed sales volume , 42 have some sodium labeling ...
Page 303
... Labeling Act . In 1973 Congress authorized an increase of 750 field positions to strengthen FDA's food safety program . This increase was in large part a result of a GAO report on the food industry which said sanitation was a major ...
... Labeling Act . In 1973 Congress authorized an increase of 750 field positions to strengthen FDA's food safety program . This increase was in large part a result of a GAO report on the food industry which said sanitation was a major ...
Page 331
... Labeling and Advertising .... 45 43 Blood and Blood Products .. 179 177 Viral & Rickettsial Products . 106 104 Bacterial & Allergenic Products ... 111 111 Total Human Drugs and Biologics .... 2,409 2,386 - 23 Animal Drugs and Feeds ...
... Labeling and Advertising .... 45 43 Blood and Blood Products .. 179 177 Viral & Rickettsial Products . 106 104 Bacterial & Allergenic Products ... 111 111 Total Human Drugs and Biologics .... 2,409 2,386 - 23 Animal Drugs and Feeds ...
Page 335
... stability , bio- 6 availability , and bioequivalence in relation to the drug ap- 7 proved in the previous application . " . O HR 3605 IH 33-494 0-84--22 PERCENTAGE JUICE LABELING Mr. WHITTEN . What is the current 335.
... stability , bio- 6 availability , and bioequivalence in relation to the drug ap- 7 proved in the previous application . " . O HR 3605 IH 33-494 0-84--22 PERCENTAGE JUICE LABELING Mr. WHITTEN . What is the current 335.
Other editions - View all
Common terms and phrases
action activities ADP systems Advisory Committee aflatoxins Agency agricultural options amendments analysis Animal Drug appropriate approval approximately assistance Association audit CFTC chemical clinical Commission's Commodity Exchange Act Commodity Futures Trading commodity pool compliance conduct Congress consumer contract market costs disease Division Drug Applications drug products effective enforcement Estimated evaluate FDA's Federal fiscal year 1985 food additives Food and Drug food irradiation Full-time Equivalent funds futures contracts futures markets Futures Trading Act Futures Trading Commission Health implementation increase industry inspections investigations labeling laboratory levels manufacturers market surveillance medical devices monitoring National National Futures Association NFA's NOVITCH Office operating Orphan Drug orphan products personnel pesticides PHILLIPS potential proposed registration regulations regulatory reports requirements RESPONSE rules safety samples staff standards testing tion toxicity Toxicology user charges vaccines WHITTEN
Popular passages
Page 46 - Commission or any officer designated by it is empowered to administer oaths and affirmations, subpoena witnesses, compel their attendance, take evidence, and require the production of any books, papers, correspondence, memoranda, or other records which the Commission deems relevant or material to the inquiry.
Page 47 - ... any failure to obey such order of the court may be punished by such court as a contempt thereof. All process in any such case may be served in the judicial district whereof such person is an inhabitant or wherever he may be found.
Page 269 - Service, which includes the Alcohol, Drug Abuse and Mental Health Administration; the Centers for Disease Control; the Food and Drug Administration; the Health Resources and Services Administration; and the National Institutes of Health.
Page 47 - State at any designated place of hearing. (c) In case of contumacy by, or refusal to obey a subpena issued to, any person, the Commission may invoke the aid of any court of the United States within the jurisdiction of which such investigation or proceeding is carried on, or where such person resides or carries on business, in requiring the attendance and testimony of witnesses and the production of books, papers, correspondence, memoranda, and other records.
Page 47 - ... a written petition praying that the order of the commission be set aside. A copy of such petition shall be forthwith served upon the commission, and thereupon the commission forthwith shall certify and file in the court a transcript of the record as hereinbefore provided.
Page 47 - ... shall forthwith certify and file in the court a transcript of the record theretofore made, including evidence received. Upon the filing of the transcript the court shall have jurisdiction to affirm, to set aside, or modify the order of the commission, and the findings of the commission as to the facts, if supported by the weight of evidence, shall in like manner be conclusive.
Page 410 - ... such covert agent to any individual not authorized to receive classified information, knowing that the information disclosed so identifies such covert agent and that the United States is taking affirmative measures to conceal such covert agent's intelligence relationship to the United States, shall be fined not more than $50,000 or imprisoned not more than ten years, or both. (b...
Page 47 - Commission employee under their direction as they may designate, the authority to disclose data and information that would separately disclose the business transactions or market positions of any person and trade secrets or names of customers...
Page 317 - For purposes of paragraph (1), the term "rare disease or condition" means any disease or condition which (A) affects less than 200,000 persons in the United States, or (B) affects more than 200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United States a drug for such disease or condition will be recovered from sales in the United States of such drug.